Citadel Advisors’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-100,059
| Closed | -$2.7M | – | 6969 |
|
|
2022
Q4 | $2.7M | Sell |
100,059
-870,046
| -90% | -$23.5M | ﹤0.01% | 2309 |
|
|
2022
Q3 | $17.4M | Buy |
970,105
+1,409
| +0.1% | +$25.3K | ﹤0.01% | 918 |
|
|
2022
Q2 | $12M | Buy |
968,696
+318,407
| +49% | +$3.96M | ﹤0.01% | 1148 |
|
|
2022
Q1 | $8.66M | Buy |
650,289
+426,569
| +191% | +$5.68M | ﹤0.01% | 1536 |
|
|
2021
Q4 | $3.48M | Buy |
223,720
+41,572
| +23% | +$647K | ﹤0.01% | 2469 |
|
|
2021
Q3 | $4.09M | Buy |
182,148
+2,951
| +2% | +$66.2K | ﹤0.01% | 2221 |
|
|
2021
Q2 | $4.08M | Sell |
179,197
-7,384
| -4% | -$168K | ﹤0.01% | 2393 |
|
|
2021
Q1 | $3.84M | Sell |
186,581
-210,294
| -53% | -$4.33M | ﹤0.01% | 2422 |
|
|
2020
Q4 | $11M | Buy |
396,875
+283,848
| +251% | +$7.84M | ﹤0.01% | 1202 |
|
|
2020
Q3 | $1.59M | Sell |
113,027
-357,924
| -76% | -$5.03M | ﹤0.01% | 2493 |
|
|
2020
Q2 | $9.71M | Buy |
470,951
+146,693
| +45% | +$3.02M | ﹤0.01% | 1102 |
|
|
2020
Q1 | $2.45M | Buy |
324,258
+306,835
| +1,761% | +$2.32M | ﹤0.01% | 2044 |
|
|
2019
Q4 | $271K | Sell |
17,423
-64,735
| -79% | -$1.01M | ﹤0.01% | 3959 |
|
|
2019
Q3 | $427K | Sell |
82,158
-114,087
| -58% | -$593K | ﹤0.01% | 3585 |
|
|
2019
Q2 | $1.78M | Buy |
+196,245
| New | +$1.78M | ﹤0.01% | 2514 |
|